Skip to content

Topic

AI Biosecurity Controls

Technical and policy measures limiting AI models' ability to aid dangerous biological design, including watermarking, access gating, and synthesis screening.

Current stories

leadershipOne report1 publisher

MI5 chief McCallum warns AI could 'change the stakes' on bioweapons

MI5 director general Sir Ken McCallum used his annual threat speech to warn that AI could 'change the stakes' on existing and even new bioweapons. Dr Filippa Lentzos of King's College London, cited by the Guardian, puts the more immediate concern with well-resourced states using AI to tweak known pathogens.

Publishers:theguardian.com

Reality

Evidence55
Adoption
Not scored
Hype gap+8
Incentives
Not scored
Confidence58
investConfirmed3 publishers

Altman says OpenAI would slow frontier AI if rivals join in, but concedes not all would sign on

OpenAI has already paused some internal training runs and says it would slow its most advanced work if rivals matched it. Anthropic, in the same week, counted five attempts to use Claude for biological weapons research.

Perspective Coverage

4 publishers
Builder
Builder 23%
Operator
Operator 42%
Investor
Investor 35%

Reality

Evidence55
Adoption
Not scored
Hype gap+30
Incentives60
Confidence50
securityOne report1 publisher

DeepMind's SynthID Bio watermark passes wet-lab tests without harming protein binders

Google DeepMind's SynthID Bio watermark matched unwatermarked binders on hit rate, affinity and sequence diversity across three wet-lab targets. The company aims it at DNA synthesis screeners, who could use the signal to auto-clear orders from safeguarded AI models.

Reality

Evidence42
Adoption18
Hype gap+18
Incentives70
Confidence45
investConfirmed4 publishers

Gates now wants firms taxed on their AI use. Nobody has defined the base.

His reversal from "manageable" to "insane" hands legislatures a fiscal instrument. But a levy on use is paid by adopters, and the only measured job damage so far sits at entry level.

Perspective Coverage

4 publishers
Builder
Builder 21%
Operator
Operator 49%
Investor
Investor 30%

Reality

Evidence55
Adoption
Not scored
Hype gap+40
Incentives45
Confidence60
buildOne report1 publisher

Open weights push protein-model safety off the API and onto the synthesis order

Almost all frontier protein models ship with open weights, out of reach of API refusals and unlearning. A LessWrong essay puts the enforcement point at DNA synthesis screening, where AI-designed novel sequences already defeat the sequence matching that providers use.

Publishers:lesswrong.com

Reality

Evidence33
Adoption15
Hype gap+18
Incentives45
Confidence44
buildOne report1 publisher

A biosafety evaluator went to the bench, and the hard part was the plasmid design

An LLM biosafety evaluator with no bench experience spent a week making fluorescent GLP-1 fusions in a community wet lab, and the account puts most of the difficulty before Day 1, in ordering DNA that works.

Publishers:lesswrong.com

Reality

Evidence32
Adoption
Not scored
Hype gap0
Incentives28
Confidence55
buildOne report1 publisher

Anthropic moves part of its biology work out of simulation and into a Bay Area wet lab

Life sciences head Eric Kauderer-Abrams confirmed the lab in a Reuters account, describing the split between in-house work and outside partners as ordinary biotech practice, while a spokesperson said the site is not there to discover drugs.

Publishers:mezha.net

Reality

Evidence42
Adoption31
Hype gap+28
Incentives68
Confidence46
productConfirmed4 publishers

Anthropic puts its biology claims on the bench in a new Bay Area wet lab

The company's head of life sciences told Reuters that real lab work is still the final test in biology. Anthropic has not said which experiments the lab is running, and it has yet to run a clinical trial.

Perspective Coverage

5 publishers
Builder
Builder 28%
Operator
Operator 35%
Investor
Investor 37%

Reality

Evidence55
Adoption40
Hype gap+30
Incentives70
Confidence57
productOne report1 publisher

Bench scientists put the bioweapon bottleneck in the wet lab

Frontier labs are citing AI-designed bioweapons to argue for new controls on synthetic DNA. Researchers who run labs told WIRED the hard part is assembling and verifying a virus, and that no fully autonomous lab exists.

Publishers:wired.com

Reality

Evidence56
Adoption26
Hype gap+38
Incentives74
Confidence51
productOne report1 publisher

AI's bioweapon risk debate spans DNA order screening, guardrails and safety warnings

The concrete misuse demonstration is four years old and came from a drug-discovery molecule generator, and the safeguard that stands between a query and a pathogen is a screening desk at a DNA synthesis vendor.

Reality

Evidence55
Adoption20
Hype gap+25
Incentives70
Confidence50